What is the difference between Eylea and Eylea HD?
Eylea HD is a higher dose, longer-acting formulation of Eylea that has been approved to treat Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR). Eylea is approved to treat these conditions in addition to Macular Edema Following Retinal Vein Occlusion (RVO) and Retinopathy of Prematurity (ROP).
Both are eye injections, but after an initial dosing period, Eylea HD does not have to be given as often as Eylea. Eylea HD is usually administered once every 8 to 12 weeks for DR or 8 to 16 weeks for wAMD and DME. Eylea is usually administered every 4 weeks, which may be extended to once every 8 weeks (2 months), depending on the condition.
Eylea was first approved on November 18, 2011, and Eylea HD was first approved on August 18, 2023.
Both Eylea and Eylea HD are made by Regeneron and there are no differences in their warnings, side effects, interactions, storage, and the way they work.
Related medical questions
- What’s the difference between Eylea, Eylea HD, and Avastin?
- Does Eylea and Eylea HD raise blood pressure?
- What is the difference between Eylea and Eylea HD?
- What’s the difference between Eylea, Eylea HD, and Avastin?
- Does Eylea and Eylea HD raise blood pressure?
- What is the difference between Eylea and Eylea HD?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions